| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.18 | 7e-07 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.17 | 3e-06 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.15 | 5e-06 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 2e-05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.22 | 3e-05 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.12 | 3e-05 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.15 | 6e-05 |